Filing Details
- Accession Number:
- 0001415889-24-024191
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-01 16:30:16
- Reporting Period:
- 2024-09-30
- Accepted Time:
- 2024-10-01 16:30:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1636178 | James Edgemond | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Cfo And Treasurer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-30 | 3,267 | $120.26 | 8,069 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-30 | 3,267 | $358.62 | 4,802 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-09-30 | 3,400 | $117.76 | 8,202 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-30 | 3,400 | $358.62 | 4,802 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-09-30 | 817 | $120.26 | 5,619 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-30 | 553 | $358.62 | 5,066 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-09-30 | 850 | $117.76 | 5,916 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-09-30 | 572 | $358.62 | 5,344 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2024-09-30 | 3,267 | $0.00 | 3,267 | $120.26 |
| Common Stock | Stock Options | Disposition | 2024-09-30 | 3,400 | $0.00 | 3,400 | $117.76 |
| Common Stock | Stock Options | Disposition | 2024-09-30 | 817 | $0.00 | 817 | $120.26 |
| Common Stock | Stock Options | Disposition | 2024-09-30 | 850 | $0.00 | 850 | $117.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 21,237 | 2017-03-15 | 2026-03-15 | No | 4 | M | Direct |
| 133,600 | 2021-03-15 | 2027-03-15 | No | 4 | M | Direct |
| 20,420 | 2017-03-15 | 2026-03-15 | No | 4 | M | Direct |
| 132,750 | 2021-03-15 | 2027-03-15 | No | 4 | M | Direct |
Footnotes
- This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on May 17, 2024.
- This option exercise was a "sell-to-cover" transaction whereby the reporting person exercised 817 stock options, sold 553 of the resulting shares of common stock, and held the remaining 264 shares of common stock.
- This option exercise was a "sell-to-cover" transaction whereby the reporting person exercised 850 stock options, sold 572 of the resulting shares of common stock, and held the remaining 278 shares of common stock.
Billionaire Hedge Funds
